Health News
A New Job for Xalkori
The US Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat patients with advanced non-small cell lung cancer (NSCLC) who have tumors with an ROS-1 gene alteration.
The Latest on Cancer in the US
Deaths from cancer have been on the decline for years, according to a new report. But there are still some trouble spots.
How Aspirin Might Affect Cancer Risk
That handy headache remedy sitting in your medicine cabinet may have some other health benefits.
The Link Between Moles and Melanoma
Melanoma and skin moles have long been associated. But there's some new information.
Is a PET Scan the Right Option for You?
For cancer survivors, vigilance is a key part of remaining cancer free. But new evidence suggests one cancer detection tool is being overused — and that isn’t helping anyone.
FDA Expands Indication For Breast Cancer Rx
On February 19, 2016, the U. S. Food and Drug Administration approved palbociclib (IBRANCE Capsules, Pfizer, Inc.) in combination with fulvestrant for the treatment of women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
For Colorectal Patients, Surgery May Not Be Enough
A colonoscopy is a medical procedure that uses a thin, flexible tube to examine the colon. Although invasive and sometimes uncomfortable, colonoscopies are essential screening tools. And that may be especially true for colorectal cancer patients.
Some Melanoma Patients May Not Need This Rx
Interferon is a medication commonly used to treat melanoma, but it may not be beneficial for some patients. And the reason why may be a good one.
The Effect of BRCA Testing on Breast Cancer Treatment
Genetic testing in younger women with breast cancer may be getting more common. And that could have an effect on those women's future treatment decisions.
New Treatment Offers Hope for Multiple Myeloma
Multiple myeloma is a hard cancer to cure. But there may be some good news on that front.